Gisela Schwab, President, Prod Development & Med Aff & CMO at EXELIXIS, INC. (EXEL), sold 50,000 shares at $23.00 ($1.1M) on 2021-04-01, disclosed to the SEC on 2021-04-02.
Seasonal sale ($1.1M) by President, Prod Development & Med Aff & CMO — this insider has traded EXEL in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| EXEL | SELL | 2021-02-19 | $2.2M | — | Filing → |
| EXEL | SELL | 2020-06-05 | $2.3M | — | Filing → |
| EXEL | SELL | 2020-04-24 | $2.6M | — | Filing → |